ArticleClinical neurology and neurosurgery2026
The current landscape of sex-based disparities in surgical treatment of essential tremor and Parkinson's disease amidst MRgFUS adoption.
Article in Clinical neurology and neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundSex disparities in surgical treatment for movement disorders such as essential Tremor (ET) and Parkinson's disease (PD) are well documented for deep brain stimulation (DBS), but remain less understood in the context of newer, less invasive procedures such as magnetic resonance-guided focused ultrasound (MRgFUS).
objectiveTo examine sex differences in the utilization of deep brain stimulation (DBS) and MRgFUS for ET and PD patients using a large, propensity score-matched cohort.
methodsData from over 600,000 ET or PD patients were analyzed from TriNetX (07/2005-06/2025). Propensity score matching balanced male and female cohorts. Hazards of receiving DBS, MRgFUS, or combined surgical treatment were compared by sex using hazard ratios (HR) with 95% confidence intervals (CI).
resultsIn the ET cohort (N = 279,600), females had a significantly lower likelihood of receiving surgical treatment compared with males (HR=0.56, 95% CI:0.53-0.59, p < 0.001), and the trends were similar for the subgroup receiving MRgFUS (HR=0.38, 95% CI:0.34-0.43, p < 0.001) and DBS (HR=0.61, 95% CI:0.58-0.64, p < 0.001). In the PD cohort (N = 344,314), females similarly exhibited lower likelihood of receiving surgical treatment compared with males (HR=0.68, 95% CI:0.65-0.70, p < 0.001), and the trends were similar for subgroup receiving MRgFUS (HR=0.53, 95% CI:0.42-0.68, p < 0.001) and DBS (HR=0.68, 95% CI:0.65-0.71, p < 0.001.
conclusionsIn this multi-institutional analysis, female patients with ET or PD were significantly less likely to undergo surgical treatment with either DBS or MRgFUS, even after adjusting for demographics and comorbidities. The persistence of this disparity despite the availability of MRgFUS suggests that barriers to surgical care extend beyond procedural invasiveness alone. Addressing these inequities will require targeted, multidisciplinary efforts spanning patient education, referral practices, and health system-level factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.